MOONLAKE IMMUNOTHERAPEUTICS Shares Outstanding (Cover Page)
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) had Shares Outstanding (Cover Page) of 85.11 million shares as of 2026-08-01, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-01: Entity Common Stock, Shares Outstanding 85.11M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 73.62M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-01 | 85.11M shares 10-Q · filed 2026-08-10 |
| 2026-05-01 | 73.62M shares 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |